173 related articles for article (PubMed ID: 10851568)
21. [Clinical cases of acquired coagulation inhibitors].
Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
[TBL] [Abstract][Full Text] [Related]
22. [Acquired factor VIII hemophilia in a geriatric patient].
Boddi W; Machetti S; Sodi N; Sammicheli L; Cati G; Marotta G; Sabatini L; Cappelli R
Ann Ital Med Int; 2005; 20(3):192-6. PubMed ID: 16250186
[TBL] [Abstract][Full Text] [Related]
23. [Acquired inhibitor against coagulation factor V with severe hematuria].
Hasegawa M; Tanaka T; Kii T; Fujiwara S; Ikeda N; Kinntaka D; Takeuti T; Tanaka H; Ikemoto T
Rinsho Ketsueki; 2003 Sep; 44(9):933-9. PubMed ID: 14577313
[TBL] [Abstract][Full Text] [Related]
24. Factor V inhibitor developing after liver transplantation in a 3-year-old child.
Gordon B; Haire W; Duggan M; Langnas A; Shaw B
Pediatrics; 1991 Jul; 88(1):156-9. PubMed ID: 2057253
[No Abstract] [Full Text] [Related]
25. Coagulation properties of fresh-frozin canine plasma during prolonged storage.
Greene CE; Beck BB
Am J Vet Res; 1980 Jan; 41(1):147-50. PubMed ID: 7362120
[TBL] [Abstract][Full Text] [Related]
26. Factor V inhibitor after injection of human thrombin (tissucol) into a bleeding peptic ulcer.
Caers J; Reekmans A; Jochmans K; Naegels S; Mana F; Urbain D; Reynaert H
Endoscopy; 2003 Jun; 35(6):542-4. PubMed ID: 12783357
[TBL] [Abstract][Full Text] [Related]
27. [A circulating inhibitor specific to factor V. Clinical, biological and therapeutic study (author's transl)].
Lerolle D; Dreyer-Dufer C; Allain JP
Nouv Presse Med; 1981 Apr; 10(18):1483-7. PubMed ID: 6789299
[TBL] [Abstract][Full Text] [Related]
28. [Factor V inhibitor with double cancer].
Okajima A; Horii J; Nasu K; Niki Y; Akasaka K; Yamashita H; Sugimoto M; Yoshioka A
Rinsho Ketsueki; 1989 Apr; 30(4):514-9. PubMed ID: 2769972
[TBL] [Abstract][Full Text] [Related]
29. Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.
Ashizawa M; Kimura S; Wada H; Sakamoto K; Sato M; Terasako K; Kikuchi M; Nakasone H; Okuda S; Kako S; Yamazaki R; Oshima K; Matsuura K; Ohmori T; Madoiwa S; Nishida J; Mimuro J; Tabei K; Sakata Y; Kanda Y
Hematology; 2013 Sep; 18(5):300-4. PubMed ID: 23683688
[TBL] [Abstract][Full Text] [Related]
30. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
31. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
[TBL] [Abstract][Full Text] [Related]
32. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
Chng WJ; Sum C; Kuperan P
Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
[TBL] [Abstract][Full Text] [Related]
33. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.
Wiwanitkit V
Clin Appl Thromb Hemost; 2006 Oct; 12(4):485-8. PubMed ID: 17000894
[TBL] [Abstract][Full Text] [Related]
34. Bovine thrombin induces an acquired coagulopathy in sensitized patients undergoing revision spinal surgery: a report of two cases.
Poynton AR; Nelson MC; McCance SE; Levine RL; O'Leary PF
Spine (Phila Pa 1976); 2003 Jun; 28(12):E221-3. PubMed ID: 12811284
[TBL] [Abstract][Full Text] [Related]
35. A case report of an acquired inhibitor to coagulation factor V.
Shanmugam H; Jayaranee S; Eow GI
Haemophilia; 2011 Jan; 17(1):168-70. PubMed ID: 20557356
[No Abstract] [Full Text] [Related]
36. Coagulation inhibitors.
Corrigan JJ
Am J Pediatr Hematol Oncol; 1980; 2(3):281-8. PubMed ID: 6776839
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment with intravenous immunoglobulin (IVIg) in a patient with an acquired factor V inhibitor after liver transplantation.
Guglielmone H; Jarchum G; Minoldo S
Thromb Haemost; 2011 Nov; 106(5):985-6. PubMed ID: 21901236
[No Abstract] [Full Text] [Related]
38. Successful management of a possible antibiotic-related acquired factor V inhibitor: a case report and review of the literature.
Motwani P; Howard L; Ali SS
Acta Haematol; 2013; 129(3):182-4. PubMed ID: 23257771
[TBL] [Abstract][Full Text] [Related]
39. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
De Bel AV; Van der Cruyssen GA; Devreese KM
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
[TBL] [Abstract][Full Text] [Related]
40. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
